Literature DB >> 12774948

Progress in clinical neurosciences: sepsis-associated encephalopathy: evolving concepts.

John X Wilson1, G Bryan Young.   

Abstract

Systemic sepsis commonly produces brain dysfunction, sepsis-associated encephalopathy, which can vary from a transient, reversible encephalopathy to irreversible brain damage. The encephalopathy in the acute phase clinically resembles many metabolic encephalopathies: a diffuse disturbance in cerebral function with sparing of the brain stem. The severity of the encephalopathy, as reflected in progressive EEG abnormalities, often precedes then parallels dysfunction in other organs. Recent research has revealed a number of potentially important, non-mutually exclusive, mechanisms that have therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12774948     DOI: 10.1017/s031716710005335x

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  44 in total

1.  Methods of monitoring shock.

Authors:  Ednan K Bajwa; Atul Malhotra; B Taylor Thompson
Journal:  Semin Respir Crit Care Med       Date:  2004-12       Impact factor: 3.119

2.  Enduring Changes in Neuronal Function upon Systemic Inflammation Are NLRP3 Inflammasome Dependent.

Authors:  Marianna M S Beyer; Niklas Lonnemann; Anita Remus; Eicke Latz; Michael T Heneka; Martin Korte
Journal:  J Neurosci       Date:  2020-06-04       Impact factor: 6.167

3.  Cerebral blood flow velocity in early-onset neonatal sepsis and its clinical significance.

Authors:  Sriparna Basu; Shashikant Dewangan; Ram Chandra Shukla; Shampa Anupurva; Ashok Kumar
Journal:  Eur J Pediatr       Date:  2012-01-04       Impact factor: 3.183

4.  Involuntary craniofacial lingual movements in intensive care-acquired quadriplegia.

Authors:  A M Cartagena; M Jog; G B Young
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

5.  Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.

Authors:  Juciano Gasparotto; Carolina S Girardi; Nauana Somensi; Camila T Ribeiro; José C F Moreira; Monique Michels; Beatriz Sonai; Mariane Rocha; Amanda V Steckert; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Daniel P Gelain
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

Review 6.  Cerebral hemodynamics in sepsis assessed by transcranial Doppler: a systematic review and meta-analysis.

Authors:  Daniel Silva de Azevedo; Angela Salomao Macedo Salinet; Marcelo de Lima Oliveira; Manoel Jacobsen Teixeira; Edson Bor-Seng-Shu; Ricardo de Carvalho Nogueira
Journal:  J Clin Monit Comput       Date:  2016-10-18       Impact factor: 2.502

7.  NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits.

Authors:  Marc Weberpals; Michael Hermes; S Hermann; Markus P Kummer; Dick Terwel; Alexander Semmler; Meike Berger; Michael Schäfers; Michael T Heneka
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

Review 8.  Septic Encephalopathy.

Authors:  Chiara Robba; Ilaria Alice Crippa; Fabio Silvio Taccone
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

9.  Impaired cerebrovascular reactivity in sepsis-associated encephalopathy studied by acetazolamide test.

Authors:  Szilárd Szatmári; Tamás Végh; Akos Csomós; Judit Hallay; István Takács; Csilla Molnár; Béla Fülesdi
Journal:  Crit Care       Date:  2010-03-31       Impact factor: 9.097

10.  Endotoxemia-induced inflammation and the effect on the human brain.

Authors:  Mark van den Boogaard; Bart P Ramakers; Nens van Alfen; Sieberen P van der Werf; Wilhelmina F Fick; Cornelia W Hoedemaekers; Marcel M Verbeek; Lisette Schoonhoven; Johannes G van der Hoeven; Peter Pickkers
Journal:  Crit Care       Date:  2010-05-05       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.